COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.
| Publicado en: | Lancet Vol. 360; no. 9339; pp. 1071 - 1074 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | letter research tables/charts Journal Article |
| Publicado: |
Lancet
10/5/2002
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106800298&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106800298 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01406736 LAN jtl: Lancet issn: 01406736 maglogo: N pubinfo: dt: 10/5/2002 vid: 360 iid: 9339 pid: 1297 pub: Lancet place: Philadelphia, Pennsylvania artinfo: ui: 106800298 106800298 2003020673 10.1016/s0140-6736(02)11131-7 NLM12383990 106800298 ppf: 1071 ppct: 3 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. aug: au: Ray WA Stein CM Daugherty JR Hall K Arbogast PG Griffin MR affil: Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232; Wayne.Ray@mcmail.vanderbilt.edu sug: subj: Antiinflammatory Agents, Non-Steroidal Adverse Effects Coronary Disease Risk Factors Cox-2 Inhibitors Adverse Effects Aged Antiinflammatory Agents, Non-Steroidal Administration and Dosage Coronary Disease Epidemiology Cox-2 Inhibitors Administration and Dosage Descriptive Statistics Drug Monitoring Medicaid Middle Age Prospective Studies Regression Retrospective Design Tennessee Funding Source Human Aged: 65+ years Middle Aged: 45-64 years pubtype: Academic Journal doctype: letter research tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|